Abstract
Cystatins A and C were both shown to inhibit cathepsin B by a two-step mechanism, involving an initial weak interaction followed by a conformational change. Disruption of the major salt bridge anchoring the occluding loop of cathepsin B to the main body of the enzyme by mutation of His110 to Ala converted the binding to an apparent one-step reaction. The second step of cystatin binding to cathepsin B must therefore be due to the inhibitor having to alter the conformation of the enzyme by displacing the occluding loop to allow a tight complex to be formed. Cystatin A was appreciably less effective in displacing the loop than cystatin C, resulting in a considerably lower overall inhibition rate constant.
Original language | English |
---|---|
Pages (from-to) | 156-156 |
Journal | FEBS Letters |
Volume | 487 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2000 |
Subject classification (UKÄ)
- Pharmacology and Toxicology
- Medicinal Chemistry